Enliven Therapeutics (NASDAQ:ELVN) Hits New 12-Month High – Should You Buy?
Enliven Therapeutics, Inc. (NASDAQ:ELVN – Get Free Report)’s share price hit a new 52-week high during mid-day trading on Friday . The stock traded as high as $31.76 and last traded at $30.05, with a volume of 4931441 shares. The stock had previously closed at $27.25. Analysts Set New Price Targets A number of equities […]
Alliance Resource Partners (NASDAQ:ARLP) Sets New 12-Month High – Should You Buy?
Alliance Resource Partners, L.P. (NASDAQ:ARLP – Get Free Report) hit a new 52-week high on Thursday . The stock traded as high as $28.80 and last traded at $28.8630, with a volume of 407796 shares traded. The stock had previously closed at $27.38. Analysts Set New Price Targets A number of brokerages recently issued reports […]
CG Oncology (NASDAQ:CGON) Reaches New 12-Month High – Should You Buy?
CG Oncology, Inc. (NASDAQ:CGON – Get Free Report)’s share price hit a new 52-week high during mid-day trading on Tuesday . The company traded as high as $63.89 and last traded at $62.6150, with a volume of 601012 shares traded. The stock had previously closed at $61.29. Wall Street Analyst Weigh In Several equities research […]
Talkspace (NASDAQ:TALK) Reaches New 12-Month High – Should You Buy?
Talkspace, Inc. (NASDAQ:TALK – Get Free Report)’s stock price hit a new 52-week high during mid-day trading on Tuesday . The company traded as high as $5.19 and last traded at $5.1650, with a volume of 4822872 shares changing hands. The stock had previously closed at $5.12. Key Headlines Impacting Talkspace Here are the key […]
Exact Sciences (NASDAQ:EXAS) Sets New 12-Month High – Should You Buy?
Exact Sciences Corporation (NASDAQ:EXAS – Get Free Report)’s share price reached a new 52-week high during trading on Monday . The company traded as high as $103.75 and last traded at $103.71, with a volume of 3185358 shares trading hands. The stock had previously closed at $103.50. Analysts Set New Price Targets Several research firms […]
last updated on 20 Mar 10:14